Impact of the duration of previous osteoporosis treatment on the effect of romosozumab in patients with postmenopausal osteoporosis.
Ebina K, Etani Y, Tsuboi H, Nagayama Y, Kashii M, Miyama A, Kunugiza Y, Hirao M, Okamura G, Noguchi T, Takami K, Goshima A, Miura T, Fukuda Y, Kurihara T, Okada S, Nakata K.
Ebina K, et al. Among authors: nagayama y.
Osteoporos Int. 2022 Nov;33(11):2441-2443. doi: 10.1007/s00198-022-06545-1. Epub 2022 Sep 6.
Osteoporos Int. 2022.
PMID: 36066579
No abstract available.